Jorge González

Prof. Dr. Jorge González


Research Focus & Metrics

Academic Career Length

45Years (1982-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2012 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
MCMelissa D. Conrad
Melissa D. Conrad
AGAndrew W. Gorman
Andrew W. Gorman
JSJulia A. Schillinger
Julia A. Schillinger
PFPier Luigi Fiori
Pier Luigi Fiori
RARossana Arroyo
Rossana Arroyo
JCJane M Carlton
Jane M Carlton
Trichomonas vaginalis is the causative agent of human trichomoniasis, the most common non-viral sexually transmitted infection world-wide. Despite its prevalence, little is known about the genetic diversity and population structure of this haploid parasite due to the lack of appropriate tools. The development of a panel of microsatellite makers and SNPs from mining the parasite's genome sequence has paved the way to a global analysis of the genetic structure of the pathogen and association with clinical phenotypes. Here we utilize a panel of T. vaginalis-specific genetic markers to genotype 235 isolates from Mexico, Chile, India, Australia, Papua New Guinea, Italy, Africa and the United States, including 19 clinical isolates recently collected from 270 women attending New York City sexually transmitted disease clinics. Using population genetic analysis, we show that T. vaginalis is a genetically diverse parasite with a unique population structure consisting of two types present in equal proportions world-wide. Parasites belonging to the two types (type 1 and type 2) differ significantly in the rate at which they harbor the T. vaginalis virus, a dsRNA virus implicated in parasite pathogenesis, and in their sensitivity to the widely-used drug, metronidazole. We also uncover evidence of genetic exchange, indicating a sexual life-cycle of the parasite despite an absence of morphologically-distinct sexual stages. Our study represents the first robust and comprehensive evaluation of global T. vaginalis genetic diversity and population structure. Our identification of a unique two-type structure, and the clinically relevant phenotypes associated with them, provides a new dimension for understanding T. vaginalis pathogenesis. In addition, our demonstration of the possibility of genetic exchange in the parasite has important implications for genetic research and control of the disease. The human parasite Trichomonas vaginalis causes trichomoniasis, the world's most common non-viral sexually transmitted infection. Research on T. vaginalis genetic diversity has been limited by a lack of appropriate genotyping tools. To address this problem, we recently published a panel of T. vaginalis-specific genetic markers; here we use these markers to genotype isolates collected from ten regions around the globe. We detect high levels of genetic diversity, infer a two-type population structure, identify clinically relevant differences between the two types, and uncover evidence of genetic exchange in what was believed to be a clonal organism. Together, these results greatly improve our understanding of the population genetics of T. vaginalis and provide insights into the possibility of genetic exchange in the parasite, with implications for the epidemiology and control of the disease. By taking into account the existence of different types and their unique characteristics, we can improve understanding of the wide range of symptoms that patients manifest and better implement appropriate drug treatment. In addition, by recognizing the possibility of genetic exchange, we are more equipped to address the growing concern of drug resistance and the mechanisms by which it may spread within parasite populations.

1 November 1996 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
JGJorge González
Jorge González
FRF J Ramalho-Pinto
F J Ramalho-Pinto
UFU Frevert
U Frevert
JGJ Ghiso
J Ghiso
STS Tomlinson
S Tomlinson
VNV Nussenzweig
V Nussenzweig
A prominent feature of the life cycle of intracellular parasites is the profound morphological changes they undergo during development in the vertebrate and invertebrate hosts. In eukaryotic cells, most cytoplasmic proteins are degraded in proteasomes. Here, we show that the transformation in axenic medium of trypomastigotes of Trypanosoma cruzi into amastigote-like organisms, and the intracellular development of the parasite from amastigotes into trypomastigotes, are prevented by lactacystin, or by a peptide aldehyde that inhibits proteasome function. Clasto-lactacystin, an inactive analogue of lactacystin, and cell-permeant peptide aldehyde inhibitors of T. cruzi cysteine proteinases have no effect. We have also identified the 20S proteasomes from T. cruzi as a target of lactacystin in vivo. Our results document the essential role of proteasomes in the stage-specific transformation of a protozoan.

1 February 1993 in Parasite Immunology
Verified
Journal Article
Closed access
PDF file
RRRita de Cassia Ruiz
Rita de Cassia Ruiz
VRVera Lucia Rigoni
Vera Lucia Rigoni
JGJorge González
Jorge González
NYNobuko Yoshida
Nobuko Yoshida

1 January 2001 in Biochemistry
Verified
Journal Article
Closed access
JDJuana L. de Diego
Juana L. de Diego
JKJeffrey M. Katz
Jeffrey M. Katz
PMPatricia Marshall
Patricia Marshall
BGBessy Gutiérrez
Bessy Gutiérrez
JMJerry E. Manning
Jerry E. Manning
JGJorge González
Jorge González

1 December 2012 in Microbes and Infection
Verified
Journal Article
Closed access
LOLuis Osorio
Luis Osorio
IRIsabel Ríos
Isabel Ríos
BGBessy Gutiérrez
Bessy Gutiérrez
JGJorge González
Jorge González

1 January 2015 in BioMed Research International
Verified
Journal Article
Open access
PDF file
CMChristian Muñoz
Christian Muñoz
JFJuan San Francisco
Juan San Francisco
BGBessy Gutiérrez
Bessy Gutiérrez
JGJorge González
Jorge González
In eukaryotic cells, proteasomes perform crucial roles in many cellular pathways by degrading proteins to enforce quality control and regulate many cellular processes such as cell cycle progression, signal transduction, cell death, immune responses, metabolism, protein-quality control, and development. The catalytic heart of these complexes, the 20S proteasome, is highly conserved in bacteria, yeast, and humans. However, until a few years ago, the role of proteasomes in parasite biology was completely unknown. Here, we summarize findings about the role of proteasomes in protozoan parasites biology and virulence. Several reports have confirmed the role of proteasomes in parasite biological processes such as cell differentiation, cell cycle, proliferation, and encystation. Proliferation and cell differentiation are key steps in host colonization. Considering the importance of proteasomes in both processes in many different parasites such asTrypanosoma, Leishmania, Toxoplasma,andEntamoeba, parasite proteasomes might serve as virulence factors. Several pieces of evidence strongly suggest that the ubiquitin-proteasome pathway is also a viable parasitic therapeutic target. Research in recent years has shown that the proteasome is a valid drug target for sleeping sickness and malaria. Then, proteasomes are a key organelle in parasite biology and virulence and appear to be an attractive new chemotherapeutic target.